Healthcare provider profile · identity verified

Jonathon E Sargent, MD

Internal Medicine · BELLEVUE, WA · NPI 1316301930

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	605	159
Amlodipine Besylate	Amlodipine Besylate	353	88
Levothyroxine Sodium	Levothyroxine Sodium	305	71
Losartan Potassium	Losartan Potassium	265	66
Omeprazole	Omeprazole	210	47
Rosuvastatin Calcium	Rosuvastatin Calcium	196	53
Tamsulosin Hcl	Tamsulosin Hcl	193	56
Gabapentin	Gabapentin	191	45
Lisinopril	Lisinopril	169	47
Metformin Hcl Er	Metformin Hcl	164	40
Simvastatin	Simvastatin	149	39
Metoprolol Succinate	Metoprolol Succinate	134	37
Trazodone Hcl	Trazodone Hcl	122	34
Telmisartan	Telmisartan	111	35
Hydrochlorothiazide	Hydrochlorothiazide	109	28
Sertraline Hcl	Sertraline Hcl	100	27
Allopurinol	Allopurinol	98	27
Eliquis	Apixaban	93	22
Metformin Hcl	Metformin Hcl	85	20
Jardiance	Empagliflozin	83	19
Albuterol Sulfate Hfa	Albuterol Sulfate	76	26
Furosemide	Furosemide	71	18
Pravastatin Sodium	Pravastatin Sodium	71	21
Zolpidem Tartrate	Zolpidem Tartrate	70	20
Pantoprazole Sodium	Pantoprazole Sodium	67	22
Alendronate Sodium	Alendronate Sodium	59	18
Ozempic	Semaglutide	55	suppressed
Famotidine	Famotidine	53	suppressed
Bupropion Xl	Bupropion Hcl	52	suppressed
Alprazolam	Alprazolam	50	14
Ezetimibe	Ezetimibe	50	12
Fluticasone Propionate	Fluticasone Propionate	47	15
Fluoxetine Hcl	Fluoxetine Hcl	46	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	13
Glipizide	Glipizide	42	11
Testosterone	Testosterone	42	suppressed
Citalopram Hbr	Citalopram Hydrobromide	41	suppressed
Synthroid	Levothyroxine Sodium	41	suppressed
Ipratropium Bromide	Ipratropium Bromide	40	12
Spironolactone	Spironolactone	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Xarelto	Rivaroxaban	39	suppressed
Finasteride	Finasteride	37	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Tizanidine Hcl	Tizanidine Hcl	36	suppressed
Duloxetine Hcl	Duloxetine Hcl	35	12
Bumetanide	Bumetanide	33	suppressed
Carvedilol	Carvedilol	33	suppressed
Montelukast Sodium	Montelukast Sodium	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Mounjaro	Tirzepatide	30	suppressed
Potassium Chloride	Potassium Chloride	30	suppressed
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Liothyronine Sodium	Liothyronine Sodium	27	suppressed
Acyclovir	Acyclovir	26	suppressed
Azelastine Hcl	Azelastine Hcl	26	suppressed
Celecoxib	Celecoxib	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Diazepam	Diazepam	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Genvoya	Elviteg/Cob/Emtri/Tenof Alafen	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Colchicine	Colchicine	24	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	23	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Estradiol	Estradiol	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Atenolol	Atenolol	20	suppressed
Donepezil Hcl	Donepezil Hcl	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Propranolol Hcl Er	Propranolol Hcl	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	15
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	13
Lovastatin	Lovastatin	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	18	suppressed
Prednisone	Prednisone	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Ramipril	Ramipril	17	suppressed
Valsartan	Valsartan	17	suppressed
Vascepa	Icosapent Ethyl	17	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Dutasteride	Dutasteride	16	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Baclofen	Baclofen	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Juluca	Dolutegravir/Rilpivirine	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Potassium Citrate Er	Potassium Citrate	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Methimazole	Methimazole	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error